0001415889-23-004099.txt : 20230303 0001415889-23-004099.hdr.sgml : 20230303 20230303161632 ACCESSION NUMBER: 0001415889-23-004099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOREVIC JASON N CENTRAL INDEX KEY: 0001208500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 23704179 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 form4-03032023_090302.xml X0306 4 2023-03-01 0001477449 Teladoc Health, Inc. TDOC 0001208500 GOREVIC JASON N C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 true true false false CHIEF EXECUTIVE OFFICER Common Stock 2023-03-01 4 M 0 22458 A 588922 D Common Stock 2023-03-02 4 S 0 8262 25.362 D 580660 D Common Stock 2023-03-02 4 M 0 9104 A 589764 D Common Stock 2023-03-02 4 M 0 15476 A 605240 D Common Stock 2023-03-02 4 M 0 3891 A 609131 D Common Stock 2023-03-02 4 M 0 7648 A 616779 D Common Stock 2023-03-02 4 M 0 5782 A 622561 D Common Stock 2023-03-02 4 M 0 2913 A 625474 D Restricted Stock Units 2023-03-01 4 M 0 22458 0 D Common Stock 22458 44918 D Restricted Stock Units 2023-03-02 4 M 0 9104 0 D Common Stock 9104 0 D Performance Stock Units 2023-03-02 4 M 0 15476 0 D Common Stock 15476 0 D Performance Stock Units 2023-03-02 4 M 0 3891 0 D Common Stock 3891 0 D Restricted Stock Units 2023-03-02 4 M 0 7648 0 D Common Stock 7648 7648 D Performance Stock Units 2023-03-02 4 M 0 5782 0 D Common Stock 5782 5782 D Performance Stock Units 2023-03-02 4 A 0 5828 0 A Common Stock 5828 5828 D Performance Stock Units 2023-03-02 4 M 0 2913 0 D Common Stock 2913 2915 D Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. On March 19, 2021, the reporting person contributed 50,000 shares of TDOC common stock to the Jason N. Gorevic Grantor Retained Annuity Trust for the benefit of himself. Upon termination of the trust on June 6, 2022, 50,000 shares were previously distributed to the reporting person and continue to be reported in this Form 4 as directly owned. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Performance stock units convert to shares of TDOC common stock on a one-for-one basis. On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 2, 2020, the reporting person was granted 27,311 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On March 2, 2021, the reporting person earned 46,430 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021 On March 2, 2022, the reporting person earned 7,784 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. On March 2, 2021, the reporting person was granted 22,944 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On March 2, 2022, the reporting person earned 17,346 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Each performance stock unit represents a contingent right to receive one share of TDOC common stock. Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022. The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. On March 2, 2023, the reporting person earned 5,828 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. /s/ Adam C. Vandervoort, Attorney-in-Fact 2023-03-03